Brendan O'Neill

Brendan Richard O'Neill currently works at The Institute of Cancer Research: Royal Cancer Hospital, as Director, Willis Ltd., as Director from 2017, and ICR Sutton Developments Ltd., as Director.
Dr. O'Neill also formerly worked at Imperial Chemical Industries Ltd., as Chief Executive Officer & Director from 1999 to 2003, Guinness Brewing Worldwide Ltd., as Chief Executive Officer from 1993 to 1998, Tyco International Ltd., as Independent Director, Ascential Group Ltd., as Non-Executive Director, HSBC Holdings Plc, as Director, Rank Group Plc, as Non-Executive Director from 2004 to 2007, Endurance Specialty Holdings Ltd., as Independent Director from 2012 to 2014, Tyco International Plc, as Director, Aegis Group Plc, as Director from 2005 to 2009, Balfour Beatty Plc, as Director, Informa Switzerland Ltd., as Non-Executive Director from 2008 to 2011, Financial Control Assc Intl, as Director, United Distillers Ltd., as Managing Director-International Region, Watson Wyatt Worldwide, Inc., as Director from 2006 to 2009, Guinness Plc, as Director, Endurance Worldwide Insurance Ltd., as Director from 2006 to 2014, Towers Watson & Co., as Independent Director from 2012 to 2016, Drambuie Ltd., as Non-Executive Director, Endurance Worldwide Holdings Ltd., as Director, Dentsu International Ltd., as Non-Executive Director from 2005 to 2009, Informa Plc, as Independent Non-Executive Director from 2008 to 2017, Willis Towers Watson Plc, as Independent Director from 2016 to 2023, Informa Group Ltd., as Director, and Ford Motor Co., as Principal from 1973 to 1975.
Dr. O'Neill received his graduate degree from the University of Cambridge and doctorate degree from the University of East Anglia.